Your browser doesn't support javascript.
loading
A targeted boost-and-sort immunization strategy using Escherichia coli BamA identifies rare growth inhibitory antibodies.
Vij, Rajesh; Lin, Zhonghua; Chiang, Nancy; Vernes, Jean-Michel; Storek, Kelly M; Park, Summer; Chan, Joyce; Meng, Y Gloria; Comps-Agrar, Laetitia; Luan, Peng; Lee, Sophia; Schneider, Kellen; Bevers, Jack; Zilberleyb, Inna; Tam, Christine; Koth, Christopher M; Xu, Min; Gill, Avinash; Auerbach, Marcy R; Smith, Peter A; Rutherford, Steven T; Nakamura, Gerald; Seshasayee, Dhaya; Payandeh, Jian; Koerber, James T.
Affiliation
  • Vij R; Department of Antibody Engineering, Genentech, 1 DNA Way, South San Francisco, California, 94080, USA.
  • Lin Z; Department of Antibody Engineering, Genentech, 1 DNA Way, South San Francisco, California, 94080, USA.
  • Chiang N; Department of Antibody Engineering, Genentech, 1 DNA Way, South San Francisco, California, 94080, USA.
  • Vernes JM; Department of Biochemical and Cellular Pharmacology, Genentech, 1 DNA Way, South San Francisco, California, 94080, USA.
  • Storek KM; Department of Infectious Diseases, Genentech, 1 DNA Way, South San Francisco, California, 94080, USA.
  • Park S; Department of Translational Immunology, Genentech, 1 DNA Way, South San Francisco, California, 94080, USA.
  • Chan J; Department of Biochemical and Cellular Pharmacology, Genentech, 1 DNA Way, South San Francisco, California, 94080, USA.
  • Meng YG; Department of Biochemical and Cellular Pharmacology, Genentech, 1 DNA Way, South San Francisco, California, 94080, USA.
  • Comps-Agrar L; Department of Biochemical and Cellular Pharmacology, Genentech, 1 DNA Way, South San Francisco, California, 94080, USA.
  • Luan P; Department of Antibody Engineering, Genentech, 1 DNA Way, South San Francisco, California, 94080, USA.
  • Lee S; Department of Antibody Engineering, Genentech, 1 DNA Way, South San Francisco, California, 94080, USA.
  • Schneider K; Department of Antibody Engineering, Genentech, 1 DNA Way, South San Francisco, California, 94080, USA.
  • Bevers J; Department of Antibody Engineering, Genentech, 1 DNA Way, South San Francisco, California, 94080, USA.
  • Zilberleyb I; Department of BioMolecular Resources, Genentech, 1 DNA Way, South San Francisco, California, 94080, USA.
  • Tam C; Department of BioMolecular Resources, Genentech, 1 DNA Way, South San Francisco, California, 94080, USA.
  • Koth CM; Department of Structural Biology, Genentech, 1 DNA Way, South San Francisco, California, 94080, USA.
  • Xu M; Department of Translational Immunology, Genentech, 1 DNA Way, South San Francisco, California, 94080, USA.
  • Gill A; Department of Antibody Engineering, Genentech, 1 DNA Way, South San Francisco, California, 94080, USA.
  • Auerbach MR; Department of Infectious Diseases, Genentech, 1 DNA Way, South San Francisco, California, 94080, USA.
  • Smith PA; Department of Infectious Diseases, Genentech, 1 DNA Way, South San Francisco, California, 94080, USA.
  • Rutherford ST; Department of Infectious Diseases, Genentech, 1 DNA Way, South San Francisco, California, 94080, USA.
  • Nakamura G; Department of Antibody Engineering, Genentech, 1 DNA Way, South San Francisco, California, 94080, USA.
  • Seshasayee D; Department of Antibody Engineering, Genentech, 1 DNA Way, South San Francisco, California, 94080, USA.
  • Payandeh J; Department of Structural Biology, Genentech, 1 DNA Way, South San Francisco, California, 94080, USA. payandeh.jian@gene.com.
  • Koerber JT; Department of Antibody Engineering, Genentech, 1 DNA Way, South San Francisco, California, 94080, USA. koerber.james@gene.com.
Sci Rep ; 8(1): 7136, 2018 05 08.
Article in En | MEDLINE | ID: mdl-29740124
Outer membrane proteins (OMPs) in Gram-negative bacteria are essential for a number of cellular functions including nutrient transport and drug efflux. Escherichia coli BamA is an essential component of the OMP ß-barrel assembly machinery and a potential novel antibacterial target that has been proposed to undergo large (~15 Å) conformational changes. Here, we explored methods to isolate anti-BamA monoclonal antibodies (mAbs) that might alter the function of this OMP and ultimately lead to bacterial growth inhibition. We first optimized traditional immunization approaches but failed to identify mAbs that altered cell growth after screening >3000 hybridomas. We then developed a "targeted boost-and-sort" strategy that combines bacterial cell immunizations, purified BamA protein boosts, and single hybridoma cell sorting using amphipol-reconstituted BamA antigen. This unique workflow improves the discovery efficiency of FACS + mAbs by >600-fold and enabled the identification of rare anti-BamA mAbs with bacterial growth inhibitory activity in the presence of a truncated lipopolysaccharide layer. These mAbs represent novel tools for dissecting the BamA-mediated mechanism of ß-barrel folding and our workflow establishes a new template for the efficient discovery of novel mAbs against other highly dynamic membrane proteins.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bacterial Outer Membrane Proteins / Escherichia coli Proteins / Escherichia coli / Antibodies, Monoclonal Language: En Journal: Sci Rep Year: 2018 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bacterial Outer Membrane Proteins / Escherichia coli Proteins / Escherichia coli / Antibodies, Monoclonal Language: En Journal: Sci Rep Year: 2018 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido